UK markets close in 6 hours 34 minutes

Beijing Tong Ren Tang Chinese Medicine Company Limited (3613.HK)

HKSE - HKSE Delayed price. Currency in HKD
Add to watchlist
9.600-0.080 (-0.83%)
At close: 04:08PM HKT
Currency in HKD

Valuation measures4

Market cap (intra-day) 8.10B
Enterprise value 5.86B
Trailing P/E 15.14
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)5.40
Price/book (mrq)2.13
Enterprise value/revenue 3.93
Enterprise value/EBITDA 7.72

Trading information

Stock price history

Beta (5Y monthly) 0.38
52-week change 3-33.70%
S&P500 52-week change 326.94%
52-week high 315.920
52-week low 38.750
50-day moving average 39.465
200-day moving average 311.249

Share statistics

Avg vol (3-month) 31.52M
Avg vol (10-day) 32.31M
Shares outstanding 5837.1M
Implied shares outstanding 6850.94M
Float 8236.31M
% held by insiders 171.77%
% held by institutions 15.60%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.33
Forward annual dividend yield 43.35%
Trailing annual dividend rate 30.33
Trailing annual dividend yield 33.41%
5-year average dividend yield 42.37
Payout ratio 450.77%
Dividend date 3N/A
Ex-dividend date 404 Jun 2024
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 35.44%
Operating margin (ttm)41.04%

Management effectiveness

Return on assets (ttm)8.98%
Return on equity (ttm)15.22%

Income statement

Revenue (ttm)1.52B
Revenue per share (ttm)1.82
Quarterly revenue growth (yoy)-35.50%
Gross profit (ttm)N/A
EBITDA 638.96M
Net income avi to common (ttm)540.39M
Diluted EPS (ttm)0.640
Quarterly earnings growth (yoy)-36.40%

Balance sheet

Total cash (mrq)2.4B
Total cash per share (mrq)2.87
Total debt (mrq)131.81M
Total debt/equity (mrq)3.28%
Current ratio (mrq)11.65
Book value per share (mrq)4.62

Cash flow statement

Operating cash flow (ttm)460.83M
Levered free cash flow (ttm)317.64M